Novel drug target ADAM8/17 is associated with the occurrence of intrahepatic cholangiocarcinoma via Notch1/Integrinα5 pathway
Novel targeted drugs are currently available for all patients with intrahepatic cholangiocarcinoma (ICC). The goal of this study was to investigate the association between A Disintegrin and Metalloproteinase8/17 (ADAM8/17) and ICC, and to determine whether ADAM8/17 could be a novel target for ICC treatment. The express...
Kaisi Yang, Lei Han, Xiaoxuan Song et al.
· Journal of Cancer Research a... · 0 citations